Article: PEGASYS and COPEGUS Achieve Highest Sustained Virological Response Ever Achieved in HIV-HCV Co-infected Patients.

Article: Roche's Pegasys and Copegus effective in in HIV-HCV ...
Pharma Marketletter;  February 23, 2004 ;     700+ words ... ... co-infected with HIV-HCV. These subjects were randomized ... receive for 48 weeks either Pegasys once-weekly in combination ... to be co-infected with HCV. Pegasys was approved by the US ... for patients with chronic HCV infection, in combination ...

Article: Journal publishes results of PEGASYS trial in ...
Biotech Business Week;  August 16, 2004 ;     700+ words ... ... hepatitis C virus (HCV). APRICOT found that the combination of Pegasys (peginterferon alfa ... interferon/ribavirin. Pegasys/Copegus therapy ... patients with HIV-HCV co-infection ... infected with HIV-HCV were randomized to receive either Pegasys 180mg once weekly ...

Article: FDA grants priority review to Pegasys with Copegus for ...
Health & Medicine Week;  November 1, 2004 ;     691 words ... ... combination therapy of Pegasys (peginterferon alfa ... chronic hepatitis C (HCV) in patients coinfected ... FDA in August 2004. Pegasys, the most prescribed ... infected with HIV and HCV. APRICOT is one of the six Pegasys studies published in ...

Article: Co-infected HCV/HIV patients achieve sustained response ...
AIDS Weekly;  August 16, 2004 ;     700+ words ... ... patients treated with Pegasys combination therapy compared to those treated with Pegasys monotherapy or conventional ... enrolled a total of 868 HCV/HIV co-infected patients ... countries. All patients were HCV positive, had compensated ... ribavirin, 180 mcg of Pegasys once weekly plus placebo ...

Article: Results of Multinational Trial Investigating PEGASYS and ...
PR Newswire;  February 7, 2004 ;     492 words ... ... results of a multinational trial - The AIDS Pegasys Ribavirin International Co-infection ... combination therapy in patients with HIV-HCV co-infection. The results of the trial ... conventional interferon and ribavirin in HIV- HCV co-infection (40% vs. 12%, P< ...

Article: PEGASYS twice as effective as current standard therapy for ...
PR Newswire;  June 30, 2003 ;     700+ words ... ... patients infected with HBV and HCV. The benefits of PEGASYS are derived from its new generation ... conventional interferon. In HCV PEGASYS provides superior efficacy compared ... conjunction with Roferon A or PEGASYS for HCV. Roche also manufactures HBV ...

Article: PEGASYS(R) Proven Effective as Hepatitis C Treatment for ...
Hepatitis Weekly;  January 26, 2009 ;     700+ words ... ... growing body of evidence that PEGASYS provides a successful outcome for many patients with HCV. PEGASYS has consistently demonstrated ... center Italian studies with PEGASYS have shown reproducible efficacy in HCV patients with genotype 1 ...